Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
about
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanNegative factor from SIV binds to the catalytic subunit of the V-ATPase to internalize CD4 and to increase viral infectivityComparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite thHTLV-1 p30II: selective repressor of gene expressionRole of Tax protein in human T-cell leukemia virus type-I leukemogenicityHuman T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytesAPOBEC3G targets human T-cell leukemia virus type 1.HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular SignalingMechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virusHuman T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expressionMolecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) proteinRole of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability.Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesisHuman T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbitsOncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase.Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins.Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.Animal Models Utilized in HTLV-1 ResearchHuman T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I.Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesHuman T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.
P2860
Q21245197-66F77434-732E-480C-90C5-B26F259580ECQ24290827-53CCA822-A30F-40DB-8650-7B399787D068Q24653987-06349FD2-3566-41A3-8D21-41E2221D7075Q24671809-57CA0258-876B-4915-A22A-1C3D7A61952FQ24798269-9EC47E53-F0CE-4F30-9014-7E3D5CDAC058Q24802464-0CA45EF4-44D0-4BE8-A733-3F79676A17E7Q24808655-46F789C0-7EB9-421F-83A3-7A6B383FBF70Q24811566-143DAE9B-6074-4CB9-BCEF-14BC3BB8832CQ26777804-D51FE8EB-3613-4606-8903-C3E40978B002Q26863681-A92C5B18-9D07-418E-BA91-9BB6D0A17DADQ30168711-F108C2AC-DEFE-41A5-AABE-BEA6C0422727Q30175334-A74E90E7-6F41-4870-82B4-2C11F8A14D82Q30698124-35325566-5242-401C-81B6-14EEA827C04EQ30991310-39533C3A-4189-4B66-85E3-B1506B0E049BQ33206633-782C4D03-CB7B-4E13-9B6F-8C7DA5A3FA4CQ33627019-8B240B9D-9AFF-4DB4-BB61-DA8520E977CDQ33779850-915A5F5A-E652-4D9E-893C-7783792174C1Q33792918-401874E6-1521-464E-B9EC-25EF2723C073Q33816840-07A098E8-2BBD-44A4-882A-2CD8375713EFQ33816914-EB57A9EC-D338-40CD-8751-B9511A42CF9AQ33819351-E42089C3-DF4D-4BC1-8391-10A19ABDD3E1Q33827304-D41ABBAE-CC9A-4ADC-AA9F-1A7DD4CF7292Q33853009-861415E4-BD5A-4AAD-A4BF-EAE5D2FD70C1Q33969941-D858BE9E-9708-4601-8E11-CD96BB446819Q34142773-38A29174-33BF-4764-814B-42A85BB80BF8Q34142780-C788E99C-93AD-4DD3-A48E-675A00DD5B72Q34233092-8068A35F-4564-4116-BD10-94863673FD69Q34258809-80B70B60-7079-4AF9-99F6-DDE2E058A12AQ34310872-A8D52327-B194-4785-85E8-5D4416437D98Q34329174-3A6794E2-6A74-4D28-BC33-BFCC35385891Q34334640-2F46BD66-AB84-4E9C-9C47-B317548B70BDQ34342784-F0A1F026-B26F-46BB-8246-629EF33AAE03Q34348086-3CEF741E-9099-4708-9C88-252805A9182BQ34353702-CDB722CD-76AB-4E54-BAFE-4B706D45CCF1Q34463104-23D39242-9042-445D-A894-E4F53B710B8AQ34545731-AC53B8DD-EFE9-4CE4-9404-750BD73960EBQ34605803-489D6E03-5206-4019-A313-751E3F6EA663Q34606461-63B4853D-D7F8-4F36-8832-BB4C79270E34Q34619705-6D7EB289-3E03-4466-BE46-C3B260A3788DQ35261245-A1AAE2E6-2EDB-432E-80C4-150B0AC0535B
P2860
Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Selective ablation of human T- ...... ces viral infectivity in vivo.
@en
Selective ablation of human T- ...... ces viral infectivity in vivo.
@nl
type
label
Selective ablation of human T- ...... ces viral infectivity in vivo.
@en
Selective ablation of human T- ...... ces viral infectivity in vivo.
@nl
prefLabel
Selective ablation of human T- ...... ces viral infectivity in vivo.
@en
Selective ablation of human T- ...... ces viral infectivity in vivo.
@nl
P2093
P1433
P1476
Selective ablation of human T- ...... ces viral infectivity in vivo.
@en
P2093
P304
P407
P577
1998-06-01T00:00:00Z